Application

PTO Form 1478 (Rev 9/2006)

OMB No. 0651-0009 (Exp 09/30/2008)

---

PTO Form 1478 (Rev 9/2006)

OMB No. 0651-0009 (Exp 09/30/2008)

Trademark/Service Mark Application, Principal Register

Serial Number: 77112708

Filing Date: 02/21/2007

To the Commissioner for Trademarks:

MARK: VEVENU (Standard Characters, see mark)
The literal element of the mark consists of VEVENU. The mark consists of standard characters, without claim to any particular font, style, size, or color.

The applicant, Glaxo Group Limited, a corporation of United Kingdom, having an address of Glaxo Wellcome House, Berkeley Avenue, Greenford, Middlesex, United Kingdom, UB60NN, requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended.

       International Class 005:  Pharmaceutical preparations and substances for the treatment and/or alleviation of diseases and disorders of the central nervous system, and psychiatric related diseases and disorders.
Intent to Use: The applicant has a bona fide intention to use or use through the applicant's related company or licensee the mark in commerce on or in connection with the identified goods and/or services. (15 U.S.C. Section 1051(b)).

Based on Foreign Registration: Applicant has a bona fide intention to use the mark in commerce on or in connection with the identified goods and/or services, and submits a copy of United Kingdom registration number 2361685, registered 04/23/2004 with a renewal date of 04/23/2014 and an expiration date of 04/23/2014, and translation thereof, if appropriate. 15 U. S.C. Section 1126(e), as amended.
Foreign Registration-1

The applicant hereby appoints Maribeth Day Case and Sherry M. Knowles, Scott E. Thompson, Charles D. Dadswell, Robert H. Brink, Teresa Hechmer Anzalone and Pamela A. May of GlaxoSmithKline, CIP-Trademarks UW2220, 709 Swedeland Road, King of Prussia, Pennsylvania, United States, 19406 to submit this application on behalf of the applicant.

The applicant hereby appoints Maribeth Day Case of GlaxoSmithKline, CIP-Trademarks UW2220, 709 Swedeland Road, King of Prussia, Pennsylvania, United States, 19406 as applicant's representative upon whom notice or process in the proceedings affecting the mark may be served.

Correspondence Information:	Maribeth Day Case
	CIP-Trademarks UW2220
	709 Swedeland Road
	King of Prussia, Pennsylvania 19406
	919 483 1803(phone)
	704 625 9190(fax)
	trademarks@gsk.com (authorized)

A fee payment in the amount of $325 will be submitted with the application, representing payment for 1 class(es).

Declaration

The undersigned, being hereby warned that willful false statements and the like so made are punishable by fine or imprisonment, or both, under 18 U.S.C. Section 1001, and that such willful false statements, and the like, may jeopardize the validity of the application or any resulting registration, declares that he/she is properly authorized to execute this application on behalf of the applicant; he/she believes the applicant to be the owner of the trademark/service mark sought to be registered, or, if the application is being filed under 15 U.S.C. Section 1051(b), he/she believes applicant to be entitled to use such mark in commerce; to the best of his/her knowledge and belief no other person, firm, corporation, or association has the right to use the mark in commerce, either in the identical form thereof or in such near resemblance thereto as to be likely, when used on or in connection with the goods/services of such other person, to cause confusion, or to cause mistake, or to deceive; and that all statements made of his/her own knowledge are true; and that all statements made on information and belief are believed to be true.


Signature: /Maribeth Day Case/   Date Signed: 02/21/2007
Signatory's Name: Maribeth Day Case
Signatory's Position: Attorney



RAM Sale Number: 512
RAM Accounting Date: 02/22/2007

Serial Number: 77112708
Internet Transmission Date: Wed Feb 21 16:51:33 EST 2007
TEAS Stamp: USPTO/BAS-XXX.XX.XXX.XXX-200702211651332
24523-77112708-360c9f3ff29a94856cf9df771
d4578137-DA-512-20070220162902362663